SALT LAKE CITY--(BUSINESS WIRE)--PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing regenerative tissue products and biomaterials, announced today that it will present at the H.C. Wainwright 22nd Annual Global Investment Conference on September 14, 2020 and the Cantor Virtual Global Healthcare Conference on September 15, 2020.
A live audio webcast of the H.C. Wainwright 22nd Annual Global Investment Conference on September 14, 2020 at 3:00 p.m. Eastern Time will be accessible in real time on the "News & Media/Events" section of PolarityTE's website at www.polarityte.com/news-media/events or via the following link:
Link to Webcast
A live audio webcast of the Cantor Virtual Global Healthcare Conference on September 15, 2020 at 11:20 a.m. Eastern Time will be accessible in real time on the "News & Media/Events" section of PolarityTE's website at www.polarityte.com/news-media/events or via the following link:
Link to Webcast
About PolarityTE®
PolarityTE is focused on transforming the lives of patients by discovering, designing and developing a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering and material sciences. Rather than manufacturing with synthetic and foreign materials within artificially engineered environments, PolarityTE manufactures products from the patient's own tissue and uses the patient's own body to support the regenerative process. From a small piece of healthy autologous tissue, the company creates an easily deployable, dynamic and self-propagating product designed to regenerate the target tissues. PolarityTE's innovative methods are intended to promote and accelerate growth of the patient's tissues to undergo a form of effective regenerative healing. Learn more at www.PolarityTE.com – Welcome to the Shift®.
POLARITYTE, the POLARITYTE logo, WHERE SELF REGENERATES SELF and WELCOME TO THE SHIFT are trademarks or registered trademarks of PolarityTE, Inc.
